Quark Venture, GF Securities unveil $500 mln health sciences fund
Canadian venture capital firm Quark Venture and GF Securities Co Ltd, a Chinese investment bank, have launched a US$500 million health sciences fund. The fund, which held an initial close of US$100 million, will invest in global biotechnology and health sciences companies. Karimah Es Sabar, recently named Quark's CEO and partner, said it will focus on building a portfolio of "game-changing innovations in drug development, medical devices, health IT and emerging convergent technologies." Quark earlier this month led the US$30 million financing of Vancouver's MSI Methylation Sciences Inc.
17 October 2016•3 mins read
